v3.26.1
Income taxes recognized in the income statement
12 Months Ended
Dec. 31, 2025
Veraxa Biotech A G [Member]  
Entity Information [Line Items]  
Income taxes recognized in the income statement

8. Income taxes recognized in the income statement

 

Current taxes are calculated on the basis of an average income tax rate of 31% on the profits generated. This expected average tax rate corresponds to the expected tax rate in Germany, as this is where the operating activities take place.

 

               
    For the
Years Ended
December 31,
 
in CHF   2025     2024  
Current taxes                
Income tax income/expense in the current financial year   -     -  
                 
Deferred taxes                
Recognized deferred (tax expense)/tax income     392,603       620,774  
Reported tax income for the current period   392,603     620,774  

 

No income taxes were recognized directly in equity or in other comprehensive income in the financial year.

 

The tax expense/income for the financial year can be reconciled to the profit/loss for the period as follows:

 

           
in CHF   December 31,
2025
    December 31,
2024
 
Earnings before income taxes   (67,006,593 )   (28,753,745 )
Income tax expense at a tax rate of 31%   20,772,044     8,913,661  
Amortization of deferred tax assets due to derecognition     -       -  
Effects of non-tax-deductible expenses and income     (12,336,984 )     (5,420,625 )
Effects of results for which no deferred taxes were recognized     (7,523,688 )     (2,666,379 )
Effects of losses for which deferred tax assets were recognized     -       -  
Tax rate differences     (428,768 )     (205,883 )
Tax amount recognized in the income statement   482,603     620,774